Avient, a provider of specialised and sustainable material solutions and services, has announced two additions to its MEVOPUR line of medical-grade materials to help producers of pharmaceutical packaging and medical devices more easily reach sustainability goals.
The new MEVOPUR products are being introduced at Pharmapack Europe 2021, being held October 13–14 in the Paris Expo Porte de Versailles.
MEVOPUR medical-grade materials are produced according to ISO13485-2016 protocols and supported by testing to ISO 10993-1, USP, European Pharmacopeia and ICH Q3D guidelines. Using MEVOPUR medical-grade materials can help manufacturers of medical devices and pharmaceutical packaging reduce the risk of regulatory non-compliance.
Masterbatches
New at Pharmapack are colour and additive masterbatches based on a polyethylene (PE) carrier that is manufactured using non-fossil feedstocks. The resins have bio-based content up to 95%, as calculated to ASTM D6866 standard. As drop-in replacements for fossil-based colour concentrates, they can be processed the same way and recycled in the same recycling channels as conventional fossil-based polyolefins.
MEVOPUR pre-coloured formulations based on bio-derived PE are also being introduced for customers who prefer ready-to-use solutions.
Foaming agents
Also being featured at Pharmapack, MEVOPUR foaming agents help manufacturers of pharmaceutical packaging and medical devices add another level of sustainability to their products. Benefits include light weighting, material savings (and therefore reduced consumption of non-renewable resources), faster cycling, and process-energy savings.
Intended for use in polyolefins, styrenics, and copolymers, these medical-grade foaming agents are the first such additives to be produced under the MEVOPUR protocols.